Picture of Geneuro SA logo

GNRO — Geneuro SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Geneuro Cash Position 16.5 Million Euros At 31 December

Jan 29 (Reuters) - GENEURO SA  GNRO.PA :
    * SOLID CASH POSITION OF EUR 16.5 MILLION, INCLUDING EUR 7.5
MILLION CREDIT FACILITY AT 31 DECEMBER
    * POSITIVE 6 MONTHS RESULTS FROM TEMELIMAB PHASE 2A TRIAL IN
ADULT
TYPE 1 DIABETES (T1D) PATIENTS
    * ONGOING PRECLINICAL DEVELOPMENT OF A NEW ANTIBODY AGAINST
AMYOTROPHIC LATERAL SCLEROSIS, AIMING TO REACH CLINIC IN 2020

Source text for Eikon:  urn:newsml:reuters.com:*:nBw7wGrbva
Further company coverage:  GNRO.PA 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Geneuro SA

See all news